Results 91 to 100 of about 50,832 (209)

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

Herpes-zóster com manifestação bucal em paciente imunossuprimido: relato de caso [PDF]

, 2013
Objetivo: O herpes-zóster é uma infecção viral causada pela reativação do vírus da varicela-zóster. Esta doença pode afetar pacientes imunossuprimidos e caracteriza-se por lesões papulovesiculares distribuídas na região inervada pelo nervo afetado ...
Cossul, Max Falchetti, Gil, Francisca Berenice Dias, Lima, Antonio Adilson Soares de, Melo, Jéssica Rivera de, Pivovar, Lorena   +4 more
core   +1 more source

Genital Herpes Zoster in an Immunocompetent Adult: A Rare Presentation

JEADV Clinical Practice, EarlyView.
Sunil Jaiswal, Shraddha Uprety, Pratichya Thapa, Aditi Joshi, Prakriti Lamichhane   +4 more
wiley   +1 more source

Infection control in the brain and the eye

Acta Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester, Paul G. McMenamin, Samantha J. Dando   +2 more
wiley   +1 more source

Clinical and morphological characteristics of herpes zoster in south India

Indian Journal of Dermatology, 2005
One hundred and seven cases (6 children and 101 adults) of herpes zoster were recruited over a period of two years. The frequency of herpes zoster amongst skin OPD cases was found to be 0.34 per cent. The male to female ratio was 1.74:1.
Dubey Anand, Jaisankar T, Thappa Devinder   +2 more
doaj  

A cross-sectional study exploring the predictors of herpes zoster vaccination for people aged over 50 years old in Chaoyang district, Beijing

Frontiers in Public Health
BackgroundVaccination is an effective measure to prevent herpes zoster and its related complications. The coverage of herpes zoster vaccination is extremely low in China, and there is a notable lack of research investigating the barriers to promoting the
Jiao Zhang, Shuo Zhang, Bin Jia, Yunhua Bai, Zhen Li, Fang Liu, Yingxue Hu, Xiaojing Guo, Jianxin Ma, Shuming Li, Qian Shi   +10 more
doaj   +1 more source

No increased risk of herpes zoster found in cirrhotic patients: a nationwide population-based study in Taiwan.

PLoS ONE, 2014
BackgroundThe association between liver cirrhosis (LC) and herpes zoster has rarely been studied. We investigated the hypothesis that LC, known as an immunodeficiency disease, may increase the risk of herpes zoster using a national health insurance ...
Ping-Hsun Wu, Yi-Ting Lin, Chun-Nan Kuo, Wei-Chiao Chang, Wei-Pin Chang   +4 more
doaj   +1 more source

Ramsay Hunt syndrome associated with ataxia: clinical case report [PDF]

Introduction: Ramsay Hunt syndrome (herpes zoster oticus) is caused by the reactivation of the varicella zoster virus, in the form of otic zoster, associated with ipsilateral peripheral facial paralysis.
Cabrera Rodríguez, Deborah, Chiappini Zayas, Stefano, Garzón Cutiño , Lisbel, Olivera Vega , Maytee   +3 more
core   +2 more sources

A Zosteriform Papular Cutaneous Eruption

JEADV Clinical Practice, EarlyView.
Silvia Borriello, Umberto Santaniello, Astrid Lappi, Paolo Borrelli, Angelo Battaglia, Roberta Patetta, Sophie Frassy, Simone Ribero, Pietro Quaglino   +8 more
wiley   +1 more source

Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐MIND Study

Cancer Science, EarlyView.
J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu, Noriko Fukuhara, Junichiro Yuda, Youko Suehiro, Shigeru Kusumoto, Marie‐Laure Casadebaig, Kazumi Suzukawa, Kentaro Fukushima   +7 more
wiley   +1 more source